Skip to main content
Log in

Recent Advances in Kawasaki Disease – Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Kawasaki disease (KD) is the most common cause of acquired heart disease in children in Japan, North America and Europe. It is now being increasingly recognized from the developing countries as well. If not diagnosed and treated in time, KD can result in coronary artery abnormalities in approximately 15–25 % cases. The long-term consequences of these abnormalities may manifest in adults as myocardial ischemia and congestive heart failure. Intravenous immunoglobulin (IVIg) remains the drug of choice for treatment of KD, but several new agents like infliximab, cyclosporine, glucocorticoids and statins are now being increasingly used in these patients. While echocardiography has been the preferred imaging modality hitherto, CT coronary angiography has emerged as an exciting new supplementary option and provides an entirely new dimension to this disease. The incidence of KD has shown a progressive increase in several countries and it is likely that this disease would impact public health programmes in the near future even in the developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sundel RP, Petty RE. Kawasaki disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of Pediatric Rheumatology. 6th ed. Philadelphia: Elsevier Saunders; 2011. p. 505–20.

    Chapter  Google Scholar 

  2. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79–85.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kumar RK, Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res. 2013;137:643–58.

    PubMed  CAS  PubMed Central  Google Scholar 

  4. Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics. 2000;106:E27.

  5. Singh S, Kawasaki T. Kawasaki disease-an Indian perspective. Indian Pediatr. 2009;46:563–71.

    PubMed  Google Scholar 

  6. Singh S, Aulakh R, Bhalla AK, Suri D, Manojkumar R, Burns JC. Is Kawasaki disease incidence rising in Chandigarh, North India? Arch Dis Child. 2011;96:137–40.

    Article  PubMed  Google Scholar 

  7. Singh S, Aulakh R, Kawasaki T. Kawasaki disease and the emerging coronary artery disease epidemic in India: is there a correlation? Indian J Pediatr. 2014; 81: 328-32.

  8. Singh S, Bansal A, Gupta A, Kumar RM, Mittal BR. Kawasaki disease: a decade of experience from North India. Int Heart J. 2005;46:679–89.

    Article  PubMed  Google Scholar 

  9. Kawasaki T Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222.

    PubMed  CAS  Google Scholar 

  10. Dean AG, Melish ME, Hick R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100:552–7.

    Article  PubMed  CAS  Google Scholar 

  11. Yanagawa H, Nakamura Y, Ojima T, Yashiro M, Tanihara S, Oki I. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J. 1999;18:64–6.

    Article  PubMed  CAS  Google Scholar 

  12. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med. 1995;149:779–83.

    Article  PubMed  CAS  Google Scholar 

  13. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995;95:475–9.

    PubMed  CAS  Google Scholar 

  14. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T. Update of the epidemiology of Kawasaki disease in Japan: from the results of 1993–1994 nationwide survey. J Epidemiol. 1996;6:148–57.

    Article  PubMed  CAS  Google Scholar 

  15. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:E65.

  16. Rodo X, Ballester J, Cayan D, et al. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep. 2011;1:152.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Burns JC, Herzog L, Fabri O, et al. Kawasaki Disease Global Climate Consortium. Seasonality of Kawasaki disease: a global perspective. PLoS One. 2013;8:e74529.

  18. Philip S, Lee W-C, Liu S-K, Wu M-H, Lue H-C. A swine model of horse-serum induced coronary vasculitis: an implication for Kawasaki disease. Pediatr Res. 2004;55:211–9.

    Article  PubMed  Google Scholar 

  19. Philip S, Lee W-C, Wu M-H, Cherian KM, Lue H-C. Histopathological evaluation of horse serum induced immune complex vasculitis in swine: implication to coronary artery lesions in Kawasaki disease. Pediatr Neonatol. 2014;55:297–305.

    Article  PubMed  Google Scholar 

  20. Burns JC, Newburger JW. Genetics insights in to the pathogenesis of Kawasaki disease. Circ Cardiovasc Genet. 2012;5:277–8.

    Article  PubMed  Google Scholar 

  21. Shrestha S, Wiener H, Shendre A, et al. Role of activating FCVR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ Cardiovasc Genet. 2012;5:309–16.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Son MB, Newburger JW. Kawasaki disease. In: Kliegman, Stanton, St. Geme Schor, Behrman A, editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders; 2011. p. 862-7.

  23. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease. Circulation. 2004;110:2747–71.

    Article  PubMed  Google Scholar 

  24. Achenbach S, Marwan M, Ropers D, et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J. 2010;31:340–6.

    Article  PubMed  Google Scholar 

  25. Dominguez SR, Anderson MS. Advances in the treatment of Kawasaki disease. Curr Opin Pediatr. 2013;25:103–9.

    Article  PubMed  Google Scholar 

  26. Okada K, Hara J, Maki I, et al. Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Eur J Pediatr. 2009;168:181–5.

    Article  PubMed  CAS  Google Scholar 

  27. Okada Y, Shinohara M, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr. 2003;143:363–7.

    Article  PubMed  CAS  Google Scholar 

  28. Newburger JW, Sleeper LA, McCrindle BW, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663–75.

    Article  PubMed  CAS  Google Scholar 

  29. Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:1731–8.

    Article  PubMed  CAS  Google Scholar 

  30. Lau AC, Duong TT, Ito S, Wilson GJ, Yeung RS. Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease. Clin Exp Immunol. 2009;157:300–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Suzuki H, Terai M, Hamada H, et al. Cyclosporin a treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30:871–6.

    Article  PubMed  Google Scholar 

  32. Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158:831–5.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J. The Harada Score in the US population of children with Kawasaki disease. Hosp Pediatr. 2014;4:233–8.

    Article  PubMed  Google Scholar 

  34. Rizk SR, El Said G, Daniels LB, et al. Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood. Am J Cardiol. 2015;115:423–7.

    Article  PubMed  Google Scholar 

  35. Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009;54:1911–20.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors express their gratitude to Dr. Jane Burns, Dr. Marian Melish, Dr. Ross Petty, and Dr. John Gordon who participated as faculty from overseas in the 3rd. Kawasaki Disease Summit, Chandigarh, October 2014.

Guarantor

SS will act as guarantor for this paper.

Conflict of Interest

None.

Source of Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Surjit Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Sharma, D., Bhattad, S. et al. Recent Advances in Kawasaki Disease – Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014. Indian J Pediatr 83, 47–52 (2016). https://doi.org/10.1007/s12098-015-1858-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-015-1858-4

Keywords

Navigation